News & Trends - MedTech & Diagnostics
Roche correcting blood glucose monitor defects
Healthcare professionals and consumers are advised that Roche Diabetes Care Australia, in consultation with the Therapeutic Goods Administration (TGA), is undertaking a product defect correction for Accu-Chek Guide and Accu-Chek Performa blood glucose meters.
It has been identified that Accu-Chek Guide blood glucose meters with serial numbers lower than 92911000001 and Accu-Chek Performa blood glucose meters with serial numbers between 68920000000 and 68925525056 (see image for serial number placement on the back of the meter) may:
- Display E-9 Errors (indicating that the batteries need to be replaced)
- Unexpectedly display the low battery icon
- Have short battery life
- Not power on.
If any of the above issues occur, it can lead to temporary meter unavailability that could cause a delay in therapy decisions, which in turn could lead to a serious medical issue.
The TGA Safety Advisory can be found at: https://www.tga.gov.au/alert/accu-chek-guide-and-accu-chek-performa-blood-glucose-meters
You may also like Injectable, flexible electrode could replace rigid nerve-stimulating implants
Register FREE to receive the latest news and insights from Health Industry Hub – the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
News & Trends - MedTech & Diagnostics
AI-assisted colonoscopy boosts polyp and adenoma detection
MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]
MoreNews & Trends - Pharmaceuticals
‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO
Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]
MoreNews & Trends - Pharmaceuticals
Government’s silence on Senate report leaves cancer patients in limbo
Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]
More